Sitemap - 2023 - Celeritas Capital

Fixed Income Fixing 12/29/23

2023 a Celeritas Review

Zealand Pharma & Axsome Therapeutics

Introducing the 'Ora Portfolio' by Celeritas

Macro outlook for the rest of 2023 + Q1 2024 outlook

A very quick post

ERs & BoE Meeting

This Week in Charts 2nd edition

Will the CPI Print be hot or cold?

Distressed Debt

ARM's China Problem

Fixed Income Fixing

This Week in Charts

Fixed Income Friday 9/1

CRISPR Therapeutics

Central Bank Bonanza

Word on The Street

The Week Ahead: 7/16-7/21

An introduction to FX trading

NQ daily trading plan for 6/30

NQ daily trading plan for 6/29

NQ daily trading plan for 6/28

NQ daily trading plan for 6/27

NQ daily trading plan for 6/26

NQ Weekly Trading Plan for 6/25-6/30

Fixed Income Friday

Midweek Charts #2

The Turkish Presidential Election

The Lovely World of Biotech Catalysts

Market Malarkey 4/23-4/28

Market Malarkey 4/16-4/21

The Banking Blame Game #1: US Regional Banks

Market Malarkey 4/2-4/7

Market Malarkey 3/26-3/31

Market Malarkey 3/19-3/24

A few mid-week thoughts

Market Malarkey 3/5-3/10

The labor market, is it finally cooling off?

Market Malarkey 2/27-3/3

Markets Malarkey 2/20-2/26

Markets Malarkey 2/13-2/17

A Brief Fixed Income Rundown

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts